If you need to sue somebody for stealing your customers with false advertising, don't worry about a conflict between two federal statutes — the Food, Drug, and Cosmetic Act and the Lanham Act. No conflict exists, the Supreme Court held today.
To understand why, let us tell you . . .
. . . a
Doing things out of proper sequence can require a do-over. But in law, as elsewhere, the do-over may come too late.
Just ask Abraxis, a drug maker that today lost a lawsuit because the company it bought patents from didn't own them at the time.
Abraxis signed an Asset Purchase Agreement with AstraZeneca in April 2006.